Abstract
Measles is a highly contagious, but vaccine-preventable disease caused by the measles virus (MeV). Although the administration of two doses of measles vaccines is the most effective strategy to prevent and eliminate measles, MeV continues to spread worldwide, even in 2022. In measles-eliminated countries, preparedness and response to measles outbreaks originating from imported cases are required to maintain elimination status. Under these circumstances, real-time reverse transcription (RT) PCR for MeV could provide a diagnostic method capable of strengthening the subnational capacity for outbreak responses. Real-time RT-PCR can detect MeV RNA from patients with measles at the initial symptomatic stage, which can enable rapid public health responses aimed at detecting their contacts and common sources of infection. Furthermore, low cycle threshold (Ct) values (i.e., high viral load) of throat swabs indicate high infectiousness in patients with measles. The high basic reproduction number of measles suggests that patients with high infectiousness can easily become super-spreaders. This opinion proposes a possible strategy of rapid and intensive responses to counter measles outbreaks caused by super-spreader candidates showing low Ct values in throat swabs. Our strategy would make it possible to effectively prevent further measles transmission, thereby leading to the early termination of measles outbreaks.
Funder
Japan Agency for Medical Research and Development
Subject
Virology,Infectious Diseases
Reference35 articles.
1. Measles;Dina;Lancet,2022
2. Nationwide molecular epidemiology of measles virus in Japan between 2008 and 2017;Seki;Front. Microbiol.,2019
3. WHO (2022, October 23). Provisional Monthly Measles and Rubella Data. Available online: http://who-wiise-frontend-prod-cdn.azureedge.net/listing.html?topic=measles-rubella&location=.
4. WHO (2022, October 23). Measles—Number of Reported Cases. Available online: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles---number-of-reported-cases.
5. Cluster-based approach to coronavirus disease 2019 (COVID-19) response in Japan, from February to April 2020;Oshitani;Jpn. J. Infect. Dis.,2020